期刊文献+

我院人血白蛋白临床应用调查分析 被引量:1

Investigation and analysis of clinical application of Human Albumin in our hospital
下载PDF
导出
摘要 目的:了解人血白蛋白(HSA)在我院住院患者中的临床使用情况,为临床合理用药及制定相应制度提供数据参考。方法:利用我院信息化管理系统及电子病历管理系统,回顾性分析我院2016年第二季度住院患者使用HSA的数据。结果:我院2016年第二季度共有596例住院患者使用HSA,以男性为主,使用范围广,年龄分布跨度大,人均使用量87.3g,人均使用HSA前三名为普外一科、干部病房和神经外科;使用量及病例数最高的适应症为单纯性低蛋白血症,占总使用量78.16%;无适应症用药为44例,以内科监护室和胸心外科最多。结论:我院临床使用HSA病例多,使用量大,几乎涉及全身各个系统疾病;临床医生对HSA适应症仍存在一定的认识误区,需进一步加强合理规范使用。 Objective :To investigate the clinical use of Human Albumin (HSA) in our hospital, and to provide data reference for clinical rational use of drugs and the establishment of the corresponding system. Methods: Using the hospital information management system and electronic medical records management system, retrospective analysis of our hospital in the second quarter of 2016 using HSA data. Result:The second quarter of 2016 a total of 596 cases of HSA patients, male dominated, the use of a wide range of age span, 87.3g per capita consumption, per capita HSA the top three for the first Department of general surgery, cadre ward and Department of Neurosurgery; and the volume of cases with the highest number of indications for simple low protein in the total amount of 78.16%; no indications of medication for 44 cases with Cardiac Surgery ICU and chest up.Conclusion:The clinical use of HSA cases in our hospital, the use of large, involving almost all systemic diseases; clinical indications for HSA there are still some misunderstanding, need to further strengthen the rational use of norms.
作者 戴永万 阮敏毅 刘文平 阮建辉 陈顺平 Dai Yongwan Ruan Minyi Liu Wenping Ruan Jianhui Chen Shunping(Zhangzhou Hospital affiliated to Fujian Medical University 36300)
出处 《北方药学》 2017年第11期173-175,共3页 Journal of North Pharmacy
关键词 人血白蛋白 合理用药 调查分析 适应症 Human serum albumin Rational drug use Investigation and analysis Indication
  • 相关文献

参考文献9

二级参考文献93

  • 1王强,李大魁,张嫄.人血白蛋白临床应用的药物利用评价[J].中国药学杂志,2005,40(13):1036-1038. 被引量:37
  • 2李向阳,王为忠,王家林.腹部外科术后肠外营养支持时补充外源性白蛋白的研究[J].陕西医学杂志,2006,35(4):451-453. 被引量:20
  • 3赵喜荣,郑永刚,郝晓菁.人血白蛋白的不良反应及分析[J].中国药物应用与监测,2007,4(1):59-62. 被引量:17
  • 4刘芳,翟所迪,田荣萍.临床应用人血白蛋白的循证医学评价[J].中国药学杂志,2007,42(6):478-480. 被引量:46
  • 5Vermeulen LC, Ratko TA, Erstad BL. A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions[J]. Arch lntern Med, 1995,155(4) : 373.
  • 6陈新谦,金有豫,汤光.新编药物学[M].第17版.北京:人民卫生出版社,2011:32-33.
  • 7OSBORN D A,EVANS N.Early volume expansion for prevention of morbidity and mortality in very preterm infants(Cochrane Review)[EB-OL].In:The Cochrane Library,Issue 1,2006.Chiehester,UK:John Wiley & Sons,Ltd.
  • 8JARDINE L A,JENKINS-MANNING S,DAVIES M W.Albumin infnsion for low serum albumin in preterm newborn infants (Cochrane Review)[EB-OL].In:The Cochrane Library,Issue 1,2006.Chichester,UK:John Wiley & Sons,Ltd.
  • 9ABOULGHAR M,EVERS J H,AL-INANY H.Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome (Cochrane Review)[EB-OL].In:The Cochrane Library,Issue 1,2006.Chichester,UK:John Wiley & Sons,Ltd.
  • 10BELLVER J,MUNOZ E A,BALLESTEROS A,et al.Intravenous albumin does not prevent moderate-severe ovarian hypemtimulation syndrome in high-risk IVF patients:a randomized controlled study[J].Hum Reprod,2003,18(11):2283-2288.

共引文献121

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部